J Wouter Jukema Selected Research

J Wouter Jukema Research Topics

3	Coronary Disease (Coronary Heart Disease) 01/2017 - 02/2011
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2010 - 05/2004
2	Atherosclerotic Plaque (Atheroma) 12/2021 - 01/2003
2	Atherosclerosis 12/2021 - 05/2004
2	ST Elevation Myocardial Infarction 08/2017 - 02/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 02/2014
2	Hemorrhage 01/2016 - 02/2012
2	Type 2 Diabetes Mellitus (MODY) 06/2012 - 12/2010
2	Thrombosis (Thrombus) 05/2010 - 07/2003
1	Rheumatoid Arthritis 08/2017
1	Vascular Diseases (Vascular Disease) 01/2017
1	Myocardial Infarction 01/2017
1	Stroke (Strokes) 01/2017
1	Chest Pain (Chest Pains) 02/2016
1	von Willebrand Diseases (von Willebrand's Disease) 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2012
1	Obesity 06/2012
1	Pancreatitis 06/2012
1	Insulin Resistance 06/2012
1	Hypertriglyceridemia 06/2012
1	Hyperlipidemias (Hyperlipidemia) 06/2012
1	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 06/2012
1	Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia) 06/2012
1	Diabetes Mellitus 06/2012
1	Hypotension (Low Blood Pressure) 02/2011
1	Neoplasms (Cancer) 02/2011
1	Abdominal Obesity 02/2011
1	Hypertriglyceridemic Waist 12/2010
1	Coronary Stenosis (Coronary Artery Stenosis) 06/2009
1	Ischemia 06/2009
1	Inflammation (Inflammations) 10/2006
1	Unstable Angina 07/2003

3	Pravastatin (Pravachol)FDA LinkGeneric 01/2017 - 05/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 05/2004
3	LipidsIBA 01/2017 - 12/2010
2	Triglycerides (Triacylglycerol)IBA 12/2021 - 12/2010
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2017 - 02/2011
2	CalciumIBA 02/2016 - 06/2009
2	Biomarkers (Surrogate Marker)IBA 02/2011 - 12/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2021
1	Anti-Citrullinated Protein AntibodiesIBA 08/2017
1	darapladibIBA 01/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	EnzymesIBA 01/2017
1	von Willebrand FactorIBA 01/2016
1	HomocysteineIBA 02/2014
1	oxidized low density lipoproteinIBA 06/2012
1	Fish OilsIBA 06/2012
1	ApolipoproteinsIBA 06/2012
1	Fibric Acids (Fibrates)IBA 06/2012
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2012
1	Clopidogrel (Plavix)FDA Link 02/2012
1	TicagrelorIBA 02/2012
1	Prasugrel Hydrochloride FDA Link 02/2012
1	Fibrinogen (Factor I)FDA Link 02/2011
1	AdiponectinIBA 02/2011
1	C-Reactive ProteinIBA 02/2011
1	Lipoproteins (Lipoprotein)IBA 02/2011
1	HDL CholesterolIBA 02/2011
1	Peroxidase (Myeloperoxidase)IBA 02/2011
1	Secretory Phospholipases A2IBA 02/2011
1	MetalsIBA 05/2010
1	Phenobarbital (Luminal)FDA Link 06/2009
1	endotoxin receptorIBA 05/2004
1	DNA (Deoxyribonucleic Acid)IBA 05/2004
1	AntigensIBA 07/2003
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 07/2003
1	atorvastatin drug combination amlodipine FDA Link 01/2003
1	Apolipoproteins E (ApoE)IBA 01/2003

2	Therapeutics 01/2017 - 02/2012
1	Secondary Prevention 01/2017
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2011
1	Drug-Eluting Stents 05/2010
1	Stents 05/2010
1	Percutaneous Coronary Intervention 10/2006